GSK reports malaria vaccine follow-up, eyes regulatory application
At a malaria conference in South Africa today, researchers reported more promising findings for a vaccine that is furthest along in development, and GlaxoSmithKline (GSK) officials said they now intend to submit a regulatory application for it to the European Medicines Agency (EMA) in 2014, according to a company press release.